Changing a drug from Rx to OTC status: The consumer behavior and public policy implications of switch drugs

Journal of Product & Brand Management

Volumn 10, Issue 1, 2001, Pages 52-64

  Creyer, Elizabeth H ^a   Hrsistodoulakis, Illias ^b   Cole, Catherine A ^c  

^a UNIVERSITY OF ARKANSAS   (United States)

^b Department of Physical Sciences   (Greece)

^c UNIVERSITY OF IOWA   (United States)

Author keywords

Brands; Consumer behaviour; Over the counter market; Pharmaceuticals; Product management

Indexed keywords

EID: 84986163929     PISSN: 10610421     EISSN: None     Source Type: Journal    
DOI: 10.1108/10610420110382821     Document Type: Article

References (23)

1. Cohen, E.P. (1990), “Are pharmaceutical ads good medicine?”, Business and Society Review, Vol. 2, Spring, pp. 8-10.
2. Cole, C. and Balasubramanian, S.K. (1993), Age Differences in Consumers’ Search for Information: Public Policy Implication, Vol. 20, June, pp. 157-69.
3. Creyer, E. and Ross, W.T. Jr (1993), “Hindsight bias and inferences in choice: the mediating effect of cognitive effort”, Organizational Behavior and Human Decision Processes, Vol. 55, pp. 61-77.
4. Gilly, M.C. and Zeithaml, V. (1985), “The elderly consumer and adoption of technology”, Journal of Consumer Research, Vol. 12, December, pp. 353-7.
5. Hoy, M.G. (1994), “Switch drugs vis-à-vis Rx and OTC: policy, marketing, and research considerations”, Journal of Public Policy & Marketing, Vol. 13, Spring, pp. 85-96.
6. Kavanoor, S., Grewal, D. and Blodgett, J. (1997), “Ads promoting OTC medications: the effect of ad format and credibility on beliefs, attitudes, and purchase intentions”, Journal of Business Research, Vol. 40, pp. 219-27.
7. (A) Majority Staff Report on the Special Committee on Aging (1989), “Prescription drug prices: are we getting our money’s worth?” United States Senate, Serial No. 101-D. Washington, DC: U.S. Government Printing Office.
8. Masson, A. and Rubin, P.H. (1985), “Matching prescriptions drugs and consumers”, New England Journal Of Medicine, Vol. 13 No. 8, pp. 513-15.
9. Morris, L.A. (1994), Prescription Drug Advertising to Consumers: Brief Summary Formats for Television and Magazine Advertisements, National Technical Information Service, PB #84-178775, Springfield, VA.
10. Morris, L.A., Tabak, E.R. and Olins, N.J. (1992), “A segmentation analysis of prescription drug information-seeking motives among the elderly,” Journal of Public Policy & Marketing, Vol. 11, Fall, pp. 115-25.
11. Morris, L.A. and Kanouse, D.A. (1981), “Consumer reactions to the tone of written drug information”, American Journal of Hospital Pharmacy, Vol. 38, May, pp. 667-71.
12. Morris, L.A., Mazis, M.B. and Brinberg, D. (1989), “Risk disclosures in televised Rx drug advertising to consumers”, Journal of Public Policy & Marketing, Vol. 8, pp. 64-80.
13. Oster, G., Huse, D.M., Delea, T.E., Colditz, G.A. and Richter, J.M. (1990), “The risks and benefits of an Rx-to-OTC switch: the case of OTC H2-Blockers”, Medical Care, Vol. 28 No. 9, pp. 834-52.
14. Rubin, P.H. (1991), “Economics of prescription drug advertising”, Journal of Research in Pharmaceutical Economics, Vol. 3 No. 4, pp. 29-39.
15. Roth, M.S. (1996), “Patterns in direct-to-consumer prescription drug print advertising and their public policy implications”, Journal of Public Policy & Marketing, Vol. 15, Spring, pp. 63-75.
16. Sheffet, M.J. and Kopp, S.W. (1990), “Advertising Rx drugs to the public: headache or relief?”, Journal of Public Policy & Marketing, Vol. 9, pp. 42-61.
17. Solan, G., Behney, C., Herdman, R., Guntow, C. and Davis, K. (1987), “Prescription drugs and elderly Americans: ambulatory use and approaches to coverage for medicare”, Office of Technology Assessment, Staff Paper, Washington DC.
18. Creyer, E.H., Bettman, J.R. and Payne, J. (1990), “The impact of accuracy and effort feedback and goals on adaptive decision makers”, Journal of Behavioral Decision Making, Vol. 3, pp. 1-16.
19. Leading National Advertisers (1992), Publishers Information Bureau, Inc. and The Arbitron Co., p. 31.
20. Naisbett, J. (1990), Megatrend 2000: The New Directions for the 1990s, Morrow, New York, NY.
21. Tabak, E.R. (1988), “Encouraging patient question-asking: a clinical trial”, Patient Education and Counseling, Vol. 12, pp. 37-49.
22. Time (1995), “Fire in the belly, money in the bank”, November 6, pp. 56-8.
23. Williams, J.R. and Hensel, P.J. (1995), “Direct-to-consumer advertising of prescription drugs”, Journal of Health Care Marketing, Vol. 15, Spring, pp. 35-41.